Literature DB >> 21526412

Development of new concepts of non-adherence measurements among users of antihypertensives medicines.

Lene Juel Kjeldsen1, Lars Bjerrum, Hanne Herborg, Pia Knudsen, Charlotte Rossing, Birthe Søndergaard.   

Abstract

OBJECTIVE: To identify various types of non-adherence among users of antihypertensive medications by establishing components of adherence measures and use these components for measuring the prevalence of non-adherence.
SETTING: Twelve community pharmacies from the Danish county of Funen.
METHOD: Users of antihypertensive medication were included in the study. 2,914 medication users received questionnaires by mail. Participating patients were asked to fill in two questionnaire regarding demographics, self-reported blood pressure, and various adherence measures. Two factor analyses were conducted based on responses to questions. MAIN OUTCOME MEASURES: Medication-taking behaviour and self-efficacy (beliefs about ability and capacity to accomplish a task), respectively. Other measures of non-adherence collected by questionnaire were also addressed in the data for comparison of prevalence with the developed concepts.
RESULTS: 1,426 (49%) participants answered the questionnaires. The analyses resulted in two sets of components: three adherence behaviour measures and two self-efficacy measures which showed similarities in concepts. The adherence behaviour measures included two concepts of intentional nonadherence (associated with aspects of self-regulation and effect concerns, respectively) and one measure of non-intentional non-adherence. Prevalence of the developed measures of behaviour related non-adherence ranged from 10.3 to 34.9% depending on which type of non-adherence measure was used. Established measures of non-adherence resulted in prevalence between 2.2 and 39.6%.
CONCLUSIONS: The study showed that concepts of non-adherence measurements could be determined including self-efficacy aspects, unintentional non-adherence and intentional non-adherence related to self-regulation and effect concerns respectively. The prevalence of the adherence behaviour components were found to be between 10.3 and 34.9%, which is in the range of expected values. Associations between the new concepts of non-adherence measurement and characteristics of nonadherers remain to be established and would be a subject for further studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526412     DOI: 10.1007/s11096-011-9509-y

Source DB:  PubMed          Journal:  Int J Clin Pharm


  26 in total

1.  Do hypertensive patients' beliefs about their illness and treatment influence medication adherence and quality of life?

Authors:  R Horne; J Clatworthy; A Polmear; J Weinman
Journal:  J Hum Hypertens       Date:  2001-08       Impact factor: 3.012

Review 2.  Evidence-based methods to enhance medication adherence.

Authors:  S D Schaffer; S J Yoon
Journal:  Nurse Pract       Date:  2001-12

3.  Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients.

Authors:  Gbenga Ogedegbe; Carol A Mancuso; John P Allegrante; Mary E Charlson
Journal:  J Clin Epidemiol       Date:  2003-06       Impact factor: 6.437

4.  The negative association of independent personality and medication adherence.

Authors:  Kathleen C Insel; Sheryl L Reminger; Chao-Pin Hsiao
Journal:  J Aging Health       Date:  2006-06

5.  Relationships between multiple self-reported nonadherence measures and pharmacy records.

Authors:  Nathaniel M Rickles; Bonnie L Svarstad
Journal:  Res Social Adm Pharm       Date:  2007-12

6.  Patient adherence to prescribed antimicrobial drug dosing regimens.

Authors:  Bernard Vrijens; John Urquhart
Journal:  J Antimicrob Chemother       Date:  2005-03-16       Impact factor: 5.790

7.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

Review 8.  When tuberculosis treatment fails. A social behavioral account of patient adherence.

Authors:  E Sumartojo
Journal:  Am Rev Respir Dis       Date:  1993-05

9.  Comparison of methods to assess medication adherence and classify nonadherence.

Authors:  Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray
Journal:  Ann Pharmacother       Date:  2009-03-03       Impact factor: 3.154

10.  Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.

Authors:  Giampiero Mazzaglia; Ettore Ambrosioni; Marianna Alacqua; Alessandro Filippi; Emiliano Sessa; Vincenzo Immordino; Claudio Borghi; Ovidio Brignoli; Achille P Caputi; Claudio Cricelli; Lorenzo G Mantovani
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

View more
  4 in total

1.  Measurement Properties of Patient-Reported Outcome Measures for Medication Adherence in Cardiovascular Disease: A COSMIN Systematic Review.

Authors:  Henok G Tegegn; Stuart Wark; Edouard Tursan d'Espaignet; M Joy Spark
Journal:  Clin Drug Investig       Date:  2022-10-01       Impact factor: 3.580

Review 2.  A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the world health organization multidimensional adherence model.

Authors:  Suliman A AlGhurair; Christine A Hughes; Scot H Simpson; Lisa M Guirguis
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-20       Impact factor: 3.738

3.  Unintentional non-adherence to chronic prescription medications: how unintentional is it really?

Authors:  Abhijit S Gadkari; Colleen A McHorney
Journal:  BMC Health Serv Res       Date:  2012-06-14       Impact factor: 2.655

4.  Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study.

Authors:  Elsy Ramia; Rony Zeenny
Journal:  Patient Prefer Adherence       Date:  2014-09-08       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.